The dynamics of the mucopolysaccharidosis market are anticipated to change in the coming years owing to improvement in the diagnosis methodologies, rising awareness of the disease, incremental healthcare spending worldwide, and the expected launch of emerging therapies. LAS VEGAS, Aug. 1,…